This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Political / Marty Makary Resigns FDA Commissioner
Domestic resignation

Marty Makary Resigns FDA Commissioner

Analysis based on 114 articles · First reported May 08, 2026 · Last updated May 14, 2026

Sentiment
-40
Attention
6
Articles
114
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The resignation of Marty Makary>>> from the United States — Food and Drug Administration>>> introduces significant uncertainty into the regulatory landscape for pharmaceuticals, biotechnology, and tobacco. Investors may face increased unpredictability in drug approval processes and policy shifts, potentially impacting stock prices of companies like Replimune Group>>> and Moderna>>> that have previously clashed with the agency.

pharmaceuticals biotechnology tobacco
Event Summary

Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous 13-month tenure, marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure came after Donald Trump>>> signed off on a plan to fire him, following intense pressure over issues such as Makary's resistance to approving flavored e-cigarettes and his handling of the abortion pill mifepristone. Makary's leadership was characterized by high turnover within the FDA, including the repeated departure of vaccine chief Vinay Prasad>>>, and unpredictable regulatory decisions that frustrated pharmaceutical executives and anti-abortion activists. Kyle Diamantas>>>, the FDA's deputy commissioner for food, has been named acting commissioner. The event highlights broader leadership vacancies within the United States — United States Department of Health and Human Services>>> and raises questions about the future direction of the FDA's policies, particularly concerning drug approvals, vaccine regulation, and tobacco products.

Entities Involved
per
Marty Makary
Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous tenure marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure creates uncertainty for several of his initiatives.
Importance 100.0 Sentiment -70.0
per
Kyle Diamantas
Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
Importance 70.0 Sentiment 10.0
per
Vinay Prasad
Vinay Prasad>>>, a close ally of Marty Makary>>>, served as the FDA's vaccine and biotech chief but was pushed out twice, contributing to the agency's internal dysfunction and leadership instability.
Importance 45.0 Sentiment -30.0
ngo
Susan B. Anthony Pro-Life America
Susan B. Anthony Pro-Life America>>> actively pushed for Marty Makary>>>'s removal due to his perceived slow-walking of a review for the abortion pill mifepristone, contributing to the political pressure he faced.
Importance 40.0 Sentiment 10.0
stock
Replimune Group
Replimune Group>>> experienced rejection of its melanoma therapy by the United States — Food and Drug Administration>>> under Marty Makary>>>'s leadership, leading to public criticism and contributing to the pressure for his ouster.
Importance 40.0 Sentiment -20.0
per
Marjorie Dannenfelser
Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, expressed satisfaction with Marty Makary's departure, hoping for a new United States — Food and Drug Administration commissioner to end mail-order abortion drug regimes.
Importance 30.0 Sentiment 10.0
per
Josh Hawley
Josh Hawley, a strong advocate for safeguards on the abortion pill, celebrated Marty Makary's exit as an opportunity for the United States — Food and Drug Administration to reset its policies.
Importance 30.0 Sentiment 10.0
priv
Glas Inc.
Glas Inc.>>> received approval for its fruit-flavored vapes from the United States — Food and Drug Administration>>>, a decision that was a major point of contention leading to Marty Makary>>>'s resignation.
Importance 20.0 Sentiment 20.0
per
Dan Hawkins
Dan Hawkins, president of Students for Life, expressed skepticism that Marty Makary's exit alone would spur change on the abortion pill issue, emphasizing Donald Trump's ultimate responsibility.
Importance 20.0 Sentiment 0.0
per
George Tidmarsh
George Tidmarsh, Marty Makary's initial pick to run the United States — Food and Drug Administration's drug center, was forced to resign due to allegations of pursuing a personal vendetta.
Importance 20.0 Sentiment -50.0
per
Richard Pazdur
Richard Pazdur, a longtime United States — Food and Drug Administration cancer specialist, retired shortly after being tapped to head the drug center, influenced by tensions with Marty Makary.
Importance 20.0 Sentiment -20.0
per
Stephen Hahn
Stephen Hahn>>> is a former FDA commissioner being considered as a potential nominee to run the United States — Food and Drug Administration>>>.
Importance 15.0 Sentiment 10.0
per
Brett Giroir
Brett Giroir>>> is a former acting FDA commissioner and Assistant Health Secretary being considered as a potential nominee to run the United States — Food and Drug Administration>>>.
Importance 15.0 Sentiment 10.0
ngo
Hong Kong Biotechnology Organization
The Hong Kong Biotechnology Organization called for organizational strength and stability at the United States — Food and Drug Administration following high-level turnover.
Importance 10.0 Sentiment 0.0
stock
Moderna
Importance 0.0 Sentiment 0.0
+ 9 more entities View on Dashboard
Relationships
Marty Makary predecessor ↔ Kyle Diamantas Marty Makary led the FDA as commissioner with Kyle Diamantas serving as his deputy. After a tumultuous tenure that ended
Marty Makary related ↔ Susan B. Anthony Pro-Life America
Kyle Diamantas related ↔ Susan B. Anthony Pro-Life America
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.